Inspire Sleep Apnea Therapy: Is it worth it?
Continuous positive airway pressure (CPAP) therapy is the frontline treatment for obstructive sleep apnea (OSA), but it isn’t the right fit for everyone. Many people struggle with the discomfort of masks, hoses, or simply cannot tolerate CPAP long-term. For those patients, Inspire sleep apnea therapy offers a surgical, FDA-approved alternative.
Inspire is an implantable device designed specifically for moderate to severe OSA patients who cannot use CPAP effectively. This article will explain how Inspire works, who qualifies, its success rates, and key considerations—including costs—so you can make an informed decision about whether it’s worth it.
What Is Inspire Sleep Apnea Therapy?
Inspire sleep apnea therapy is a surgically implanted device that treats OSA by stimulating the hypoglossal nerve, which controls tongue movement and other airway muscles. By delivering mild electrical pulses in sync with your breathing, Inspire keeps the airway open during sleep, preventing the collapse that causes apneas. The device is FDA approved for certain adults with moderate to severe OSA and teens with Down syndrome with severe OSA who can’t tolerate CPAP.
The Inspire device is implanted under the skin in the chest with leads connecting to the hypoglossal nerve and near the diaphragm. Patients activate the device each night with a handheld remote, and can adjust the stimulation strength as needed.
How Effective Is Inspire Therapy?
Clinical studies and real-world data show that Inspire is highly effective for its intended population.
- Success rates for Inspire therapy are reported at around 72–75% at one and five years post-implantation, with significant reductions in apnea-hypopnea index (AHI) and improvements in daytime sleepiness scores.
- One study found a median AHI reduction from 33 to 10 at 12 months.
- 90% of bed partners reported soft snoring or no snoring.
While Inspire improves symptoms, it may not completely eliminate OSA for all patients.
Additionally, outcomes have been shown to be better in patients who meet certain criteria (e.g., lower BMI, female sex, no complex comorbidities).
What Are the Pros and Cons of Inspire Therapy?
Like most treatment options, there are several pros and cons to consider before starting Inspire therapy for sleep apnea.
Pros
- No external mask, hose, or machine required—making it more comfortable and less intrusive than CPAP.
- Silent and discreet.
- Simple nightly use with a remote control.
- Convenient for travel and daily use.
- Customizable stimulation levels for personalized comfort.
- High therapy adherence rates and long-term effectiveness.
- Covered by many insurance plans for eligible patients.
- Significant improvements in sleep quality, daytime alertness, and quality of life for both patients and their partners.
Related questions
- Why am I not losing weight on Mounjaro?
- How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss?
- Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
Cons
- Requires a surgical procedure, with associated risks such as infection, discomfort, or device-related complications.
- Not suitable for all OSA patients—only those with moderate to severe OSA who cannot tolerate CPAP and meet specific anatomical criteria.
- Some patients may experience side effects like tongue discomfort or swallowing issues, though serious adverse events are rare (about 6%).
- Device and procedure are costly, and not all insurance plans may cover the full expense.
- Battery replacement surgery may be needed after several years.
- High upfront cost ($30,000–$40,000 before insurance).
- May not fully resolve sleep apnea symptoms for everyone.
What Does Inspire Sleep Apnea Therapy Cost?
The total cost of Inspire therapy—including the device, surgical implantation, and follow-up care—can range from $30,000 to $40,000 or more without insurance coverage. Most major insurance companies, including Medicare, cover Inspire for eligible patients, but out-of-pocket costs will depend on your specific plan and deductible. Pre-authorization may be required before your insurance plan will cover Inspire. Ongoing device management costs include battery replacement and follow-up appointments.
Who Is a Good Candidate for Inspire Therapy?
Not everyone is a good fit for Inspire therapy. Ideal candidates for Inspire therapy must meet certain criteria.
Adults
- Diagnosed with moderate to severe OSA (AHI between 15 and 100).
- Cannot tolerate positive airway pressure therapy, or not getting a consistent benefit.
- Body Mass Index (BMI) under 40.
- No complete concentric collapse at the soft palate, as determined by a drug-induced sleep endoscopy (DISE).
- No significant comorbidities that would increase surgical risk.
Teens with Down syndrome
- Diagnosed with severe OSA (AHI 10-50).
- Cannot tolerate positive airway pressure therapy, or not getting a consistent benefit.
- Continue to have symptoms despite adenotonsillectomy.
A thorough evaluation by a sleep specialist is required to determine eligibility.
Conclusion
Inspire sleep apnea therapy is a breakthrough for adults with moderate to severe OSA and teens with Down syndrome and severe OSA who cannot tolerate CPAP. It offers a mask-free, highly effective alternative with sustained benefits and high patient satisfaction. However, it is only suitable for a specific subset of patients and involves surgical risks and significant costs. For those who qualify, Inspire can dramatically improve sleep quality and overall health, making it a worthwhile option to consider after other treatments have failed. Talk to your doctor to find out if Inspire therapy is right for you.
References
- American Academy of Sleep Medicine. 2024. FDA approves next-generation Inspire V therapy system. Accessed on May 28, 2025 at https://aasm.org/fda-approves-next-generation-inspire-v-therapy-system/
- Bestourous, D. E., et. al. 2020. Adverse events associated with the Inspire implantable hypoglossal nerve stimulator: A MAUDE database review. American journal of otolaryngology, 41(6), 102616. https://doi.org/10.1016/j.amjoto.2020.102616
- Costantino, A., et. al. 2020. Hypoglossal nerve stimulation long-term clinical outcomes: a systematic review and meta-analysis. Sleep & breathing = Schlaf & Atmung, 24(2), 399–411. https://doi.org/10.1007/s11325-019-01923-2
- Epstein, L. J., et. al. 2009. Clinical Guideline for the Evaluation, Management and Long-term Care of Obstructive Sleep Apnea in Adults. In: Journal of Clinical Sleep Medicine. Accessed on May 28, 2025 at https://aasm.org/resources/clinicalguidelines/osa_adults.pdf
- Inspire. Accessed on May 28, 2025 at https://www.inspiresleep.com/en-us/
- National Council on Aging. 2024. Inspire Sleep Apnea Device Review 2025. Accessed on May 28, 2025 at https://www.ncoa.org/adviser/sleep/inspire-sleep-apnea-device-review/
- Thaler, E., et. al. 2020. Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. The Laryngoscope, 130(5), 1333–1338. https://doi.org/10.1002/lary.28286
- United States Food and Drug Administration. 2023. Inspire Upper Airway Stimulation – P130008/S090. Accessed on May 28, 2025 at https://www.fda.gov/medical-devices/recently-approved-devices/inspire-upper-airway-stimulation-p130008s090
Read next
Can you get tirzepatide from a compounding pharmacy?
Some pharmacies or clinics may supply compounded versions of medicines like tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) to patients, but the FDA has issued safety warnings about this practice. Concerns have risen over active ingredients, side effects and labeling of these compounded products. Continue reading
Is Zepbound covered by insurance?
To find out if Zepbound is covered by your insurance, call and ask about your formulary drug benefits and copay or check the website. Your plan phone number is located on the back of your insurance card. Eli Lilly also offers a $25 copay savings card for patients with commercial insurance. Continue reading
What happens when you stop taking Zepbound?
If you stop using Zepbound for weight loss or obstructive sleep apnea (OSA), you will most likely regain much of the weight you have lost or you may lose the beneficial effects for OSA over time. The improvement in apnea in people with OSA is most likely related to body weight reduction with Zepbound. Continue reading
See also:
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Related medical questions
- How does Zepbound help treat sleep apnea?
- How do I know if I have sleep apnea? The warning signs
- Is sleep apnea the hidden cause of your high blood pressure?
- Can sleep apnea kill you? Understanding the real risks?
- Can tonsils cause sleep apnea and should they be removed?
- Atrial Fibrillation: The most Commonly Occurring Heartbeat Problem
- How do I control my sleep apnea?
Related support groups
- Sleep Apnea (24 questions, 102 members)